Advertisement

Topics

Psylin Neurosciences, Inc. Company Profile

18:26 EDT 17th June 2018 | BioPortfolio

Psylin Neurosciences, Inc. was formed in January, 2007 as a 50/50 joint venture biotechnology company spun out of Amylin Pharmaceuticals, Inc. and PsychoGenics, Inc. Psylin's mission is to pioneer the development of peptide therapeutics in neuropsychiatric disorders. Psylin has access to molecules in Amylin's PHORMOL library and to PsychoGenics' proprietary drug discovery technologies. Amylin's expertise in peptide biology, manufacturing and drug delivery, combined with PsychoGenics' expertise in preclinical neuropharmacology, provide Psylin with a unique drug discovery resource. Psylin has the right to develop a number of drug candidates in psychiatric disorders emerging from this collaboration.


News Articles [35 Associated News Articles listed on BioPortfolio]

ProMIS Neurosciences: ProMIS Neurosciences to Present at Upcoming Investor Conferences

TORONTO, Ontario and CAMBRIDGE, Massachusetts - January 25, 2018- ProMIS Neurosciences, Inc., a biotechnology company focused on the discovery and development of precision treatments for neurodege...

Minerva Neurosciences, Inc.: Minerva Neurosciences Names Remy Luthringer as Executive Chairman and William Doyle as Lead Independent Director

WALTHAM, Mass., 2018-02-05 14:30 CET (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a biopharmaceutical company focused on the development of therapies to treat central nervous syst...

Minerva Neurosciences, Inc.: Minerva Neurosciences Announces Enrollment of First Patient in Phase 2b Trial Comparing Seltorexant (MIN-202) Versus Quetiapine as Adjunctive Therapy to Antidepressants in Patients With Major Depressive Disorder

WALTHAM, Mass., 2017-12-21 14:00 CET (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat centr...

Minerva Neurosciences, Inc.: Minerva Neurosciences to Report Fiscal 2017 Fourth Quarter and Year End Financial Results and Business Updates on March 12, 2018

Management to host conference call WALTHAM, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the developme...

Minerva Neurosciences, Inc.: Minerva Neurosciences Screens First Patient in Phase 3 Trial Of MIN-101 to Treat Negative Symptoms in Schizophrenia

Multi-center, international trial targets significant unmet need for which no treatments are approved Approximately 500 patients to be enrolled at 60 clinical sites in U.S. and EuropeWALTHAM, Mass....

Minerva Neurosciences, Inc.: Minerva Neurosciences Reports Fiscal 2017 Fourth Quarter and Year End Financial Results and Business Updates

Four late-stage trials underway, targeting schizophrenia, major depressive disorder and insomnia disorder Planning for commercialization moves forward Management to host conference call today at 8...

Rio Grande Neurosciences assets acquired by Endonovo in $4.5M deal

Intellectual property and assets from Rio Grande Neurosciences were acquired by Endonovo Therapeutics for $3 million in cash  -More- 

Investor Network: Minerva Neurosciences Inc to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 12, 2018 / Minerva Neurosciences Inc (NASDAQ: NERV) will be discussing their earnings results in their Q4 Earnings Call to be held on March 12, 2018 at 8:30 AM Eas...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Myobloc [Solstice Neurosciences, LLC]

Myobloc (rimabotulinumtoxinB) Injection

PubMed Articles [72 Associated PubMed Articles listed on BioPortfolio]

Psychoanalysis and neurosciences: fuzzy outlines? Notes on the notion of cerebral plasticity.

"Psychoanalysis versus psychiatry" and "unconscious versus brain" are classic oppositions between different perspectives on the human being and mental suffering. This article draws on certain elements...

Artwork Description.

Neuroanniversary 2018.

Neurosocialities: Anthropological Engagements with the Neurosciences.

Moyamoya (もやもや): When cerebral arteries go up in smoke.

Clinical Trials [9 Associated Clinical Trials listed on BioPortfolio]

Enhancing Social Interaction With an AlterEgo Artificial Agent

The objective of AlterEgo is the creation of an interactive cognitive architecture, implementable in various artificial agents, allowing a continuous interaction with patients suffering fr...

Neurosciences-Intensive Care Unit Electrical Stimulation

Patients admitted to the Neurosciences Intensive Care Unit (NSICU) are at particular risk of developing ICU-associated weakness and myopathy, given the unique risks of early mobilization i...

Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies

The project will improve scientific knowledge regarding a recent law applying potentially to every french driver. It will give for the first time an indication on the impact of alerting tr...

Hippocampus Study: Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological Markers

The development of a new automated method of measurement of the volume of the hippocampus allows confirming these results in patients presenting with pre-dementia AD, treated with donepezi...

Cohorts and Collections: Clinical and Genetic Study of Parkinson's Disease and Epilepsies

The DNA and Cell Bank of Instituts Federatifs de Recherche (IFR) of Neurosciences has been running for the last 15 years at the Institut National de la Santé Et de la Recherche Médicale ...

Companies [50 Associated Companies listed on BioPortfolio]

Psylin Neurosciences, Inc.

Psylin Neurosciences, Inc. was formed in January, 2007 as a 50/50 joint venture biotechnology company spun out of Amylin Pharmaceuticals, Inc. and PsychoGenics, Inc. Psylin's mission is to pioneer the...

Merz Neurosciences

Merz Neurosciences is a division of Merz North America, a specialty healthcare company that develops and commercializes treatment solutions in aesthetics, dermatology and neurosci...

Nautilus Neurosciences, Inc.

Nautilus Neurosciences, Inc. is a neurology-focused specialty pharmaceutical company committed to providing the healthcare community with medically relevant products and services ...

Ester Neurosciences Ltd

Ester Neurosciences Ltd. is a development stage biopharmaceutical company committed to the discovery and development of novel therapeutic products for the treatment of neurological disorders such as m...

Knopp Neurosciences Inc.

Knopp Neurosciences, based in Pittsburgh, PA, USA, is a drug discovery and development company focused on delivering breakthrough treatments for neurological disorders through inn...

More Information about "Psylin Neurosciences, Inc." on BioPortfolio

We have published hundreds of Psylin Neurosciences, Inc. news stories on BioPortfolio along with dozens of Psylin Neurosciences, Inc. Clinical Trials and PubMed Articles about Psylin Neurosciences, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Psylin Neurosciences, Inc. Companies in our database. You can also find out about relevant Psylin Neurosciences, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record